In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
Molecule AI is revolutionising drug discovery by using artificial intelligence to predict molecular combinations and ...
The Alzheimer’s field is being turned on its head as mounting evidence points to the disease beginning outside the brain many ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before ...
Multiple dismissals have occurred at Cal State Bakersfield as an investigation probes who knew what and when.
A Senate hearing probed whether the Food and Drug Administration's process for approving rare-disease therapies is ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
The tissue grafts have the potential to help thousands of Americans on transplant waitlists—amid a shortage of donor livers.
6don MSN
Smart materials and drug delivery could exploit lipid molecules that reorganize at drying interfaces
Minor changes in moisture level can promote lipid molecules to reorganize themselves in biomaterial or biomembranes. This can ...
Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the ...
Chemists from St. Petersburg University has developed a new family of luminescent iridium complexes that, for the first time, realize a unique mechanism of photoactivated proton transfer. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results